Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer-Reference-Cited by-同舟云学术

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer

Author:

Hu Wenwei¹,Yang Yang²,Zhang Longzhen¹,Yin Jianxin¹,Huang Jingwei¹,Huang Lei¹,Gu Hua¹,Jiang Gening²,Fang Jianmin¹³⁴

Affiliation:

1. School of Life Sciences and Technology; Tongji University; Shanghai China

2. Shanghai Pulmonary Hospital; Shanghai China

3. Tongji University Suzhou Institute; Suzhou Jiangsu China

4. Collaborative Innovation Center for Biotherapy; West China Hospital; Sichuan University; Chengdu Sichuan China

Funder

National Basic Research of China 973 program

Suzhou Science and Technology Project

Natural Science Foundation of Shanghai

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference56 articles.

1. Cancer Statistics, 2015;Siegel;Ca-Cancer J Clin.,2015

2. Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?;Uzel;Balk Med J.,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献